Weight loss drugs can cut dementia risk by a staggering 45% Two new studies published in JAMA Neurology reveal that GLP-1 receptor agonists, like Ozempic and Trulicity, may significantly reduce the risk of dementia, particularly in individuals with type 2 diabetes.
","author_name":"Daily SumUp"}